(S (NP (PRP We)) (VP (VBP develop) (NP (NP (DT a) (JJ prediction-based) (JJ prescriptive) (NN model)) (PP (IN for) (S (VP (S (VP (VBG learning) (NP (NP (JJ optimal) (JJ personalized) (NNS treatments)) (PP (IN for) (NP (NNS patients)))))) (PP (VBN based) (PP (IN on) (NP (NP (PRP$ their) (JJ Electronic) (NNP Health) (NNP Records)) (PRN (-LRB- -LRB-) (NP (NNP EHRs)) (-RRB- -RRB-)))))))))) (. .))
(S (NP (PRP$ Our) (NN approach)) (VP (VBZ consists) (PP (IN of) (: :) (S (ADJP (PRN (-LRB- -LRB-) (NN i) (-RRB- -RRB-)) (VP (VBG predicting) (NP (NP (JJ future) (NNS outcomes)) (PP (IN under) (NP (DT each) (JJ possible) (NN therapy)))) (S (VP (VBG using) (NP (DT a) (JJ robustified) (JJ nonlinear) (NN model)))))) (, ,) (CC and) (VP (PRN (-LRB- -LRB-) (NN ii) (-RRB- -RRB-)) (VP (VBG adopting) (NP (NP (DT a) (JJ randomized) (NN prescriptive) (NN policy)) (VP (VBN determined) (PP (IN by) (NP (DT the) (JJ predicted) (NNS outcomes)))))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBP show) (NP (NP (JJ theoretical) (NNS results)) (SBAR (WHNP (WDT that)) (S (VP (VBP guarantee) (NP (NP (DT the) (JJ out-of-sample) (JJ predictive) (NN power)) (PP (IN of) (NP (DT the) (NN model))))))))) (, ,) (CC and) (VP (VB prove) (NP (NP (DT the) (NN optimality)) (PP (IN of) (NP (DT the) (JJ randomized) (NN strategy)))) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (DT the) (VBN expected) (JJ true) (JJ future) (NN outcome))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBP apply) (NP (DT the) (VBN proposed) (NN methodology)) (S (VP (TO to) (VP (VB develop) (NP (NP (JJ optimal) (NNS therapies)) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ type) (CD 2) (NNS diabetes)) (CC or) (NP (NN hypertension))))))) (S (VP (VBG using) (NP (NP (NNP EHRs)) (PP (IN from) (NP (NP (DT a) (JJ major) (JJ safety-net) (NN hospital)) (PP (IN in) (NP (NNP New) (NNP England)))))))))))) (, ,) (CC and) (VP (VBP show) (SBAR (IN that) (S (NP (PRP$ our) (NN algorithm)) (VP (VBZ leads) (PP (TO to) (NP (NP (DT a) (JJR larger) (NN reduction)) (PP (IN of) (NP (NP (NP (DT the) (NNP HbA1c)) (, ,) (PP (IN for) (NP (NNS diabetics)))) (, ,) (CC or) (NP (NP (JJ systolic) (NN blood) (NN pressure)) (, ,) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (NN hypertension)))))))) (, ,) (PP (VBN compared) (PP (TO to) (NP (DT the) (NNS alternatives))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (PRP$ our) (NN approach)) (VP (VBZ outperforms) (NP (NP (DT the) (NN standard)) (PP (IN of) (NP (NN care)))) (PP (IN under) (NP (DT the) (JJ robustified) (JJ nonlinear) (JJ predictive) (NN model))))))) (. .))
